Proton pump inhibitors—a widely used class of drugs used to treat acid reflux and related symptoms—may lead to an increased risk of fractures in children and adolescents, reports a study in the Journal of Pediatric Gastroenterology ...
Mar 17, 2020
0
2
A recently discovered protein, alpha-synuclein, has become one of the most attractive targets for developing new drugs with the potential to slow down or arrest the progression of Parkinson's disease (PD). Experts in the ...
Dec 20, 2018
0
0
Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that it is a drug with a manageable safety profile and promising antitumour activity, especially in patients with metastatic cutaneous ...
Jun 3, 2024
0
0
Early laboratory tests are the first to successfully use an experimental molecular therapy to block a hard-to-target part of a protein complex linked to several types of invasive cancer.
Feb 5, 2013
0
0
The COVID-19 virus is constantly changing as it moves from person to person. To fight the virus today and prepare for what it may look like tomorrow, researchers need to be able to track its development.
Jun 15, 2020
0
2
Wearable sensors are not just useful for personal fitness tracking, but can also be used to gain new insights in several fields of biomedical research. In a research article publishing February 27 in the open access journal ...
Feb 27, 2018
0
3
The influenza virus is an annual threat to public health around the world. Rapid changes in viral surface proteins (antigens), however, make it difficult to identify antibodies with broadly neutralizing activity against different ...
Feb 1, 2019
0
0
A glove and armband that gives people with upper limb prosthetics a sense of touch through haptic feedback is in development at the University of Bath, with a unique at-home trials set to begin in the coming weeks.
Sep 13, 2023
0
5
An article published by Technion researchers in Nature presents new insights about the evolution of the immune system. The team's findings highlight the modularity and flexibility of the evolution of immunity.
Jun 21, 2024
0
25
A new study of nearly 149,000 women with diabetes over 14 years showed an overall 18% reduced breast cancer risk for women who used low-dose aspirin compared to those who did not. The study design and results are published ...
Jun 8, 2017
0
0
